Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -2.417.3270.7146.60-54.32

What is the latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is -2.41 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-2.41
Mar20237.32
Mar202270.71
Mar202146.60
Mar2020-54.32

How is EBIT Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -2.41
Negative
Mar2023 7.32
-89.65
Mar2022 70.71
51.74
Mar2021 46.6
Positive
Mar2020 -54.32 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹34,413.6 Cr -10.4% -0.6% -11.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,363.0 Cr -2.8% -3.6% 10.8% Stock Analytics
DIVIS LABORATORIES ₹158,396.0 Cr -2.5% 1.5% 59.1% Stock Analytics
CIPLA ₹117,088.0 Cr -1.5% 0.2% 1.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,458.0 Cr -1.6% -9.2% -4.3% Stock Analytics
ZYDUS LIFESCIENCES ₹94,002.4 Cr -7.4% -5.1% 9.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-10.4%

-0.6%

-11.9%

SENSEX

-2.7%

-0.4%

6.4%


You may also like the below Video Courses